Blog

Introducing AD-NeuroScore, an innovative approach to early Alzheimer’s disease detection and tracking. Developed by Jennifer Bramen, PhD, at Pacific Neuroscience Institute Foundation, this novel solution uses advanced MRI technology and a unique algorithm to simplify and improve Alzheimer’s-specific neurodegeneration assessment. 

Expert neuro-oncologist Santosh Kesari, MD, PhD, Director of Neuro-oncology at Pacific Neuroscience Institute and Chair and Professor of the Department of Translational Neurosciences at Saint John’s Cancer Institute, published the results from a phase 2 clinical trial for recurrent glioblastoma (rGBM), offering hope for improved survival outcomes and pushing novel treatment one step closer to FDA approval.

Named among the nation’s top 50 neurology and neurosurgery centers, Pacific Neuroscience Institute (PNI)'s pituitary experts are at the forefront of research in the advancement of treatment and follow-up care for pituitary diseases. Daniel F. Kelly, MD, MD, Co-Founder of PNI and recipient of the Southern California Super Doctors Distinction for 15 years, discusses innovations in pituitary and brain tumor treatment.

Read the inspiring story of Ashley, who faced a brain cancer diagnosis after a sudden seizure. Learn how her customized treatment plan at Pacific Neuroscience Institute® helped her manage the tumor and recover her health.

As her tumor swells, a new cancer intelligence platform at Pacific Neuroscience Institute brings Cynthia Herrera closer to her care team.

Parkinson’s disease is a progressive disease of the nervous system marked by tremor, muscular rigidity, and slow, imprecise movement.

An AVM, or arteriovenous malformation, is a rare disease (approximately 1-5 out of 10,000 patients) of the blood vessels in the brain.

The Covid-19 virus is a shape-shifter. Two years into the pandemic, we’re still learning about the damage it can cause. One thing for sure: It causes more strokes, says Dr. Garni Barkhoudarian, a neurosurgeon at PNI.